量化患者对耐火性慢性自发性疹治疗方法的偏好
Olufemi Babalola1, Richard Hass1, John McAna1
1Jefferson College of Population Health, Thomas Jefferson University, Philadelphia, Pa.
概括
患者对耐火性慢性自发性疹症 (rCSU) 治疗的偏好表明疗效和施用方式是关键. 患者优先控制症状,接受一些风险,以便在rCSU管理中获得更好的结果.
科学领域:
- 皮肤病学 皮肤病学
- 药物经济学 药物经济学
- 患者报告的结果
背景情况:
- 以患者为中心的方法在药物开发和监管过程中变得越来越重要.
- 了解患者的优先事项对于优化耐火性慢性自发性疹 (rCSU) 治疗至关重要.
研究的目的:
- 量化患者对当前和新兴耐火性慢性自发性疹病 (rCSU) 治疗特征的偏好.
- 确定患者愿意在治疗特征方面做出的关键权衡.
主要方法:
- 在线离散选择实验调查对成年患者进行了自我报告的rCSU.
- 受访者评估了基于症状控制,服用方式和安全风险的假设治疗概况.
主要成果:
- 疗效 (症状控制) 和施用方式是治疗选择中最重要的因素.
- 局部治疗优先于输液,但患者会接受输液以显著改善疗效.
- 患者愿意接受可逆性功能障碍的风险增加,以更好地控制症状或缓解.
结论:
- 研究结果为开发和评估未来的rCSU疗法提供了宝贵的见解.
- 纳入患者偏好可以指导产品开发人员和监管机构在rCSU治疗优化.
相关概念视频
01:22Methods of reducing fever
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
01:29Decreased Body Temperature
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...